CVT 303 |
|
(CAS 95635-55-5) |
 |
Description: |
Ranolazine is an antianginal medication.
Ranolazine is believed to have its effects via altering the transcellular late sodium current. It affects the sodium-dependent calcium channels during myocardial ischemia in rabbits by altering the intracellular sodium level [1]. Thus, ranolazine indirectly prevents the calcium overload that causes cardiac ischemia in rats [2]. The effects of ranolazine on the NaV 1.7 and NaV 1.8 sodium channels also make it potentially useful in the treatment of neuropathic pain. Ranolazine produced dose-dependant analgesia on mechanical allodynia induced by CFA injection, but had no effect on thermal hyperalgesia [3, 4].
|
Product No. |
KT00314 |
Product Name |
CVT 303 |
Synonyms |
Ranolazine |
Formal Name |
|
CAS Number |
95635-55-5 |
Molecular Formula |
C24H33N3O4 |
Formula Weight |
427.54 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
2 years |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
A-803467
Amiloride
Dibucaine
Lamotrigine
Moricizine
Phenytoin
Riluzole
Triamterene
Vinpocetine
|
|